FreeTender
Accepting bidsitbPoland

Poland – Pharmaceutical products – ZAKUP PRODUKTU LECZNICZEGO STOSOWANEGO W CHEMIOTERAPII -MIRVETUXIMABUM SORAVTANSINUM

Poland – Pharmaceutical products – BUILDING OF MEDICINAL PRODUCT USED IN CHEMIoteRAPY -MIRVETUXIMABUM SORVTANSINUMEnglish, machine translated

Issued by Szpital Kliniczny im. ks. Anny Mazowieckiej · via TED — Tenders Electronic Daily (EU)

Verify & apply on the official portal →
Published
9 Nov 2026
Closes
24 Nov 2026, 23:59 UTC
Value
PLN 3,103,680
Reference
775833-2026
Location
Poland
Sector
Healthcare & Pharma
Type
goods

At a glance

Szpital Kliniczny im. ks. Anny Mazowieckiej in Poland has published an invitation to bid in healthcare & pharma: “Poland – Pharmaceutical products – ZAKUP PRODUKTU LECZNICZEGO STOSOWANEGO W CHEMIOTERAPII -MIRVETUXIMABUM SORAVTANSINUM”. Submissions close on 24 November 2026, 12 days from today. The stated value is PLN 3,103,680. Quote reference 775833-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 19 notices from this buyer since 2026, 10 of them currently open. There are 1,070 open healthcare & pharma notices in Poland on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

To bid on EU public procurement

Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.

English summary

Machine translated from Polish by FreeTender. The original notice below is the binding text.

DESCRIPTION OF THE CONTRACT SUBJECT MATTER. The subject of the order is the purchase and successive delivery of the medicinal product used in chemotherapy - mirvetuximabum soravtansinum for the Hospital Pharmacy according to the Ordering Authority's orders. The contractor may offer a product authorised in the territory of the Republic of Poland – in accordance with the requirements of the Act of 6 September 2001 (Journal of Laws of 2025, item 750).

Details

OPIS PRZEDMIOTU ZAMÓWIENIA. Przedmiotem zamówienia jest zakup i sukcesywne dostawy produktu leczniczego stosowanego w chemioterapii - mirvetuximabum soravtansinum dla Apteki Szpitalnej zgodnie z zamówieniami Zamawiającego. Wykonawca może zaoferować produkt dopuszczony do obrotu na terytorium Rzeczypospolitej Polskiej – zgodnie z wymogami ustawy z dnia 6 września 2001 r. Prawo Farmaceutyczne (Dz.U. z 2025 r., poz. 750).

Lots Lot 1 — ZAKUP PRODUKTU LECZNICZEGO STOSOWANEGO W CHEMIOTERAPII -MIRVETUXIMABUM SORAVTANSINUM (estimated 3103680): Przedmiotem zamówienia jest zakup i sukcesywne dostawy produktu leczniczego stosowanego w chemioterapii - mirvetuximabum soravtansinum dla Apteki Szpitalnej zgodnie z zamówieniami Zamawiającego. Szczegółowy opis przedmiotu zamówienia zawarty jest w formularzu asortymentowo-cenowym stanowiącym załącznik nr 1 do SWZ.

Buyer: Szpital Kliniczny im. ks. Anny Mazowieckiej

Buyer country: POL

Procedure: open

CPV code: 33600000

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 19 notices from Szpital Kliniczny im. ks. Anny Mazowieckiej, going back to September 2026 — 10 of them still open. There are 1,070 open Healthcare & Pharma tenders in Poland. This one closes in 12 days.

Similar Healthcare & Pharma tenders

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →